AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaInformation ScienceNamed GroupsHealth CareGeographicals
Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationTransplantation ChimeraBone Marrow TransplantationStem CellsGraft vs Leukemia EffectRecurrenceTreatment OutcomeMyeloablative AgonistsTissue DonorsBusulfanRemission InductionGraft vs Tumor EffectVidarabineGraft SurvivalHistocompatibility TestingLeukemia, Myeloid, AcuteLeukemiaImmunosuppressive AgentsLymphocyte TransfusionRetrospective StudiesMultiple MyelomaCombined Modality TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSiblingsWhole-Body IrradiationCytomegalovirus InfectionsCord Blood Stem Cell TransplantationSalvage TherapyMinor Histocompatibility AntigensHematopoietic Stem CellsLymphocyte DepletionSurvival AnalysisDisease-Free SurvivalPrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic SyndromesHistocompatibilityNeoplasm, ResidualAntilymphocyte SerumSurvival RateLiver TransplantationVirus ActivationChimerismTime FactorsMelphalanT-LymphocytesHepatic Veno-Occlusive DiseaseCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsCytomegalovirusAcute DiseaseHematopoietic Stem Cell MobilizationMesenchymal Stem Cell TransplantationFollow-Up StudiesAnemia, AplasticHLA AntigensPrimary MyelofibrosisPrognosisCell TransplantationHematologic DiseasesTransplantation ImmunologyKidney TransplantationLeukemia, Myeloid, Accelerated PhaseImmunosuppressionAntigens, CD34Embryonic Stem CellsCytarabineAntibodies, NeoplasmLeukemia, MyeloidRoseolovirus InfectionsBenzamidesAntineoplastic AgentsLymphoproliferative DisordersFusion Proteins, bcr-ablImmunocompromised HostGraft RejectionHodgkin DiseaseAdult Stem CellsNuclear FamilyTransplantation, IsogeneicPyrimidinesReceptors, Purinergic P2X5Lymphoma, Non-HodgkinLeukocyte TransfusionCyclosporineGranulocyte Colony-Stimulating FactorGanciclovirImmunotherapy, AdoptiveInfectionPiperazinesFatal OutcomeFlow CytometryHeart TransplantationOpportunistic Infections

No FAQ available that match "reduced intensity relapse after allogeneic allogeneic stem cell transplantation"